SIRION Biotech GmbH

General information

SIRION Biotech GmbH
Am Haag 6
82166 Graefelfing, Bavaria
Germany

Contact person: Christian O. Thirion, Managing Director and Founder
Company main phone: +49 (89) 700 961 99 0
Website: https://www.sirion-biotech.com

Year founded:	2006
Source of foundation:	Independent foundation

Corporate description / mission:
SIRION Biotech's goal is to spark a new generation of viral vector technologies for gene and cell therapy as well as vaccine development. SIRION evolves novel therapeutic viral vectors and uses proprietary technology platforms based on lenti-, adeno-, and adeno-associated viruses to expedite its partners’ advances in drug development.

State of ownership: Subsidiary
Headquarters: HQ: No

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Cell culture
CRO (Contract Research Organization)
Screening

Primary therapeutic areas:

Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology

Business model:

Manufacturer
Out-licensing
Research on contract basis
Service company
Subsidiary

Customer segments:

Large biotech & big pharma
Small biotech

Distribution:

Direct (own sales force)
Indirect (independent dealer)

Summary Products / Services / Technologies

Technology used:
RNAiONE™
BAC technology, etc.